Cristina Scavone
Rome, 00165, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 104 publications
Hepatic Safety Profile of Atomoxetine and Methylphenidate in Patients with ADHD: Disproportionality Analysis Using EudraVigilance Database Data.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: May 07, 2026
Ocular disorders during treatment with GLP-1 receptor agonists: a systematic review and meta-analysis of observational studies.
Journal: Frontiers in pharmacology
Published: February 10, 2026
Hepatobiliary adverse drug reactions during treatment with olaparib: an analysis of data from the EudraVigilance reporting system.
Journal: Frontiers in drug safety and regulation
Published: October 31, 2025
Hypogammaglobulinemia and infections in patients with multiple sclerosis treated with anti-CD20 monoclonal antibodies: a systematic review and meta-analysis of observational studies.
Journal: Expert opinion on drug safety
Published: October 13, 2025
Correction: Major Adverse Cardiovascular Events Related to JAK Inhibitors: A Disproportionality Analysis Using the WHO Global Individual Case Safety Database.
Journal: Drug safety
Published: June 23, 2025
Correction: Major Adverse Cardiovascular Events Related to JAK Inhibitors: A Disproportionality Analysis Using the WHO Global Individual Case Safety Database.
Journal: Drug safety
Published: April 22, 2025
The Potential Benefits of a Novel Food Supplement Based on Cannabis Sativa, Boswellia, and Fish Oil for Pain and Inflammation in Physical Activity: Unraveling the Role of Orexin-A Modulation.
Journal: Sports (Basel, Switzerland)
Published: April 17, 2025
Hepatobiliary disorders and Direct-Acting Antiviral (DAA) therapies: real-world evidence and insights from the EudraVigilance database.
Journal: Expert opinion on drug safety
Published: April 17, 2025
Hypogammaglobulinemia in patients with multiple sclerosis receiving disease modifying therapies: disproportionality analysis using the EudraVigilance database.
Journal: Expert opinion on drug safety
Published: April 16, 2025
Facts and figures of the compassionate use of onco-hematological drugs from 2016 to 2021: Results from the multicentric observational study Compass-O.
Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: March 13, 2025
Major Adverse Cardiovascular Events Related to JAK Inhibitors: A Disproportionality Analysis Using the WHO Global Individual Case Safety Database.
Journal: Drug safety
Published: February 17, 2025
Artificial intelligence-based pharmacological approach in non-small cell lung cancer in the precision medicine era.
Journal: Cancer treatment and research communications
Published: February 14, 2025
Last Updated: 09/26/2026